Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Weaver

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Follow-up report on the outcome of patients relapsing after autologous marrow transplantation for malignant lymphomaC H Weaver, F Appelbaum, F B Petersen, et al.
Cancer Treatment and Research|January 1, 1995
High-dose chemotherapy and autologous stem cell transplantation for breast cancerC H Weaver, R Birch, L S Schwartzberg, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's diseaseC H Weaver, L Schwartzberg, W Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell supportK A Schulman, R Birch, B Zhen, et al.
Seminars in Oncology|August 1, 1997
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancerR Birch, C H Weaver, J D Hainsworth, et al.
American Journal of Clinical Oncology|August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapyC H Weaver, B Zhen, L Schwartzberg, et al.
Experimental Hematology|December 1, 1995
Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patientsA A Ross, M Loudovaris, B Hazelton, et al.
Blood|November 15, 1995
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapyC H Weaver, B Hazelton, R Birch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cellsC H Weaver, K A Schulman, B Wilson-Relyea, et al.
Bone Marrow Transplantation|March 24, 1998
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphomaC H Weaver, L Schwartzberg, S Rhinehart, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Follow-up report on the outcome of patients relapsing after autologous marrow transplantation for malignant lymphomaC H Weaver, F Appelbaum, F B Petersen, et al.
Cancer Treatment and Research|January 1, 1995
High-dose chemotherapy and autologous stem cell transplantation for breast cancerC H Weaver, R Birch, L S Schwartzberg, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's diseaseC H Weaver, L Schwartzberg, W Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell supportK A Schulman, R Birch, B Zhen, et al.
Seminars in Oncology|August 1, 1997
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancerR Birch, C H Weaver, J D Hainsworth, et al.
American Journal of Clinical Oncology|August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapyC H Weaver, B Zhen, L Schwartzberg, et al.
Experimental Hematology|December 1, 1995
Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patientsA A Ross, M Loudovaris, B Hazelton, et al.
Blood|November 15, 1995
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapyC H Weaver, B Hazelton, R Birch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cellsC H Weaver, K A Schulman, B Wilson-Relyea, et al.
Bone Marrow Transplantation|March 24, 1998
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphomaC H Weaver, L Schwartzberg, S Rhinehart, et al.
Pageof 6